Works matching IS 03407004 AND DT 2002 AND VI 51 AND IP 11-12

Results: 12

41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 603, doi. 10.1007/s00262-002-0327-x

By:

Atanackovic, Djordje;
Nierhaus, Axel;
Neumeier, Michael;
Hossfeld, Dieter K.;
Hegewisch-Becker, Susanna

Publication type:

Article

Phase I/II study of sequential chemoimmunotherapy (SCIT) for metastatic melanoma: outpatient treatment with dacarbazine, granulocyte-macrophage colony-stimulating factor, low-dose interleukin-2, and interferon-alpha.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 630, doi. 10.1007/s00262-002-0323-1

By:

Groenewegen, Gerard;
Bloem, Andries;
de Gast, Gijsbert C.

Publication type:

Article

Adjuvant immunotherapy for solid tumors: from promise to clinical application.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 583, doi. 10.1007/s00262-002-0308-0

By:

Mocellin, Simone;
Rossi, Carlo R.;
Lise, Mario;
Marincola, Francesco M.

Publication type:

Article

The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 645, doi. 10.1007/s00262-002-0314-2

By:

Paul, Stephane;
Regulier, Etienne;
Poitevin, Yves;
Hormann, Horst;
Acres, R. Bruce

Publication type:

Article

Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 614, doi. 10.1007/s00262-002-0328-9

By:

Tsuboi, Akihiro;
Oka, Yoshihiro;
Udaka, Keiko;
Murakami, Masaki;
Masuda, Tomoki;
Nakano, Akiko;
Nakajima, Hiroko;
Yasukawa, Masaki;
Hiraki, Akio;
Oji, Yusuke;
Kawakami, Manabu;
Hosen, Naoki;
Fujioka, Tatsuya;
Wu, Fei;
Taniguchi, Yuki;
Nishida, Sumiyuki;
Asada, Momotaro;
Ogawa, Hiroyasu;
Kawase, Ichiro;
Sugiyama, Haruo

Publication type:

Article

Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 637, doi. 10.1007/s00262-002-0324-0

By:

Märten, Angela;
Flieger, Dimitri;
Renoth, Sabine;
Weineck, Silvia;
Albers, Peter;
Compes, Markus;
Schöttker, Björn;
Ziske, Carsten;
Engelhart, Steffen;
Hanfland, Peter;
Krizek, Ludmila;
Faber, Cora;
von Ruecker, Alexander;
Müller, Stefan;
Sauerbruch, Tilman;
Schmidt-Wolf, Ingo G.H.

Publication type:

Article

Analysis of the antibody repertoire of lymphoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 655, doi. 10.1007/s00262-002-0320-4

By:

Huang, Shaoming;
Preuss, Klaus-Dieter;
Xie, Xiaoxun;
Regitz, Evi;
Pfreundschuh, Michael

Publication type:

Article

Synopsis of the 4th Walker's Cay Meeting on Cancer Vaccines, 7–10 March 2002.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 674, doi. 10.1007/s00262-002-0341-z

By:

Mitchell, Malcolm S.;
Kast, W. Martin

Publication type:

Article

Efficient carcinoma cell killing by activated polymorphonuclear neutrophils targeted with an Ep-CAM×CD64 (HEA125×197) bispecific antibody.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 621, doi. 10.1007/s00262-002-0326-y

By:

Schweizer, Christof;
Strauss, Gudrun;
Lindner, Matthias;
Marmé, Alexander;
Deo, Yashwant M.;
Moldenhauer, Gerhard

Publication type:

Article

Linomide administration following bone marrow transplantation in mice.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 596, doi. 10.1007/s00262-002-0311-5

By:

Weiss, Lola;
Abdul-Hai, Ali;
Shufaro, Yoel;
Reich, Shoshanna;
Slavin, Shimon

Publication type:

Article

Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 663, doi. 10.1007/s00262-002-0325-z

By:

Schott, Matthias;
Feldkamp, Joachim;
Klucken, Melanie;
Kobbe, Guido;
Scherbaum, Werner A.;
Seissler, Jochen

Publication type:

Article

Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 669, doi. 10.1007/s00262-002-0317-z

By:

Pecher, Gabriele;
Häring, Arnt;
Kaiser, Lothar;
Thiel, Eckhard

Publication type:

Article